ABRAXAS2 and esophageal squamous cell carcinoma: In the correlation analysis between FAM175B expression and clinical variables in 75 ESCC patients, despite no significant difference, the patients with negative expression of FAM175B tend to have worse pathological grades and TNM stages (Table S1).